HMOX1 and hepatocellular carcinoma: Prior work in aortic aneurysms noted linear regression of HO-1 expression with anticoagulation [44], yet clinical data do not support routine anticoagulation for HCC with macrovascular invasion due to bleeding risk and absent survival benefit [45].